摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N‑(5‑acetyl‑4‑methylthiazol‑2‑yl)‑2‑chlorobenzamide | 303127-29-9

中文名称
——
中文别名
——
英文名称
N‑(5‑acetyl‑4‑methylthiazol‑2‑yl)‑2‑chlorobenzamide
英文别名
N-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-2-chlorobenzamide
N‑(5‑acetyl‑4‑methylthiazol‑2‑yl)‑2‑chlorobenzamide化学式
CAS
303127-29-9
化学式
C13H11ClN2O2S
mdl
——
分子量
294.762
InChiKey
RQTVXCMTCQZIPK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.398±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    87.3
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    N‑(5‑acetyl‑4‑methylthiazol‑2‑yl)‑2‑chlorobenzamide氢溴酸 、 pyridinium hydrobromide perbromide 作用下, 以 溶剂黄146 为溶剂, 生成 N-[5-(2-bromoacetyl)-4-methyl-1,3-thiazol-2-yl]-2-chlorobenzamide
    参考文献:
    名称:
    4′-Methyl-4,5′-bithiazole-based correctors of defective ΔF508-CFTR cellular processing
    摘要:
    The synthesis and Delta F508-CFTR corrector activity of a 148-member methylbithiazole-based library are reported. Synthetic routes were devised and optimized to generate methylbithiazole analogs in four steps. Corrector potency and efficacy were assayed using epithelial cells expressing human Delta F508-CFTR. These structure-activity data establish that the bithiazole substructure plays a critical function; eight novel methylbithiazole correctors were identified with low micromolar potencies. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.03.037
  • 作为产物:
    参考文献:
    名称:
    Synthesis, Characterization, Crystal Structure and Biological Study of Carboxamides Obtained from 2-Aminothiazole Derivatives
    摘要:
    通过乙基2-氨基-4-甲基噻唑-5-羧酸盐或1-(2-氨基-4-甲基噻唑-5-基)乙烷-1-酮与四种取代的羰基氯在0°C下反应,合成了两系列新型噻唑基羧酰胺衍生物,产率极佳。所有产物均通过FTIR、1H NMR光谱和质谱进行了表征。通过X射线分析研究了四种化合物的晶体结构。对所有合成化合物进行了针对大肠杆菌、铜绿假单胞菌、金黄色葡萄球菌和酿脓链球菌的抗菌活性筛选,以及针对白色念珠菌、黑曲霉和棒状曲霉的抗真菌活性筛选。本研究描述了由2-氨基噻唑衍生物获得的羧酰胺的生物活性和晶体结构研究。由于这些酰胺在单一挥发性溶剂中的不溶性,晶体是在混合溶剂中生长的。
    DOI:
    10.1007/s10870-019-00800-w
点击查看最新优质反应信息

文献信息

  • 4′-Methyl-4,5′-bithiazole-based correctors of defective ΔF508-CFTR cellular processing
    作者:Choong Leol Yoo、Gui Jun Yu、Baoxue Yang、Lori I. Robins、A.S. Verkman、Mark J. Kurth
    DOI:10.1016/j.bmcl.2008.03.037
    日期:2008.4
    The synthesis and Delta F508-CFTR corrector activity of a 148-member methylbithiazole-based library are reported. Synthetic routes were devised and optimized to generate methylbithiazole analogs in four steps. Corrector potency and efficacy were assayed using epithelial cells expressing human Delta F508-CFTR. These structure-activity data establish that the bithiazole substructure plays a critical function; eight novel methylbithiazole correctors were identified with low micromolar potencies. (c) 2008 Elsevier Ltd. All rights reserved.
  • Synthesis, Characterization, Crystal Structure and Biological Study of Carboxamides Obtained from 2-Aminothiazole Derivatives
    作者:Sachin S. Wazalwar、Anita R. Banpurkar、Franc Perdih
    DOI:10.1007/s10870-019-00800-w
    日期:2020.12
    Two series of novel thiazolylcarboxamide derivatives were synthesized by the reaction of ethyl 2-amino-4-methylthiazole-5-carboxylate or 1-(2-amino-4-methylthiazol-5-yl)ethan-1-one with four substituted carbonyl chlorides at 0 °C in excellent yield. All products were characterized by FTIR, 1H NMR spectroscopy and mass spectrometry. Crystal structures of four compounds were studied by X-ray analysis. All the synthesized compounds were screened against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pyogenes for antibacterial activity and against Candida albicans, Aspergillusniger and Aspergillus clavatus for antifungal activity. Present study describes the biological activity and crystal structure study of carboxamides obtained from 2-aminothaizol derivatives. Owing to the insolubility of these amides in single volatile solvent, crystals were grown in a mixture of solvents.
    通过乙基2-氨基-4-甲基噻唑-5-羧酸盐或1-(2-氨基-4-甲基噻唑-5-基)乙烷-1-酮与四种取代的羰基氯在0°C下反应,合成了两系列新型噻唑基羧酰胺衍生物,产率极佳。所有产物均通过FTIR、1H NMR光谱和质谱进行了表征。通过X射线分析研究了四种化合物的晶体结构。对所有合成化合物进行了针对大肠杆菌、铜绿假单胞菌、金黄色葡萄球菌和酿脓链球菌的抗菌活性筛选,以及针对白色念珠菌、黑曲霉和棒状曲霉的抗真菌活性筛选。本研究描述了由2-氨基噻唑衍生物获得的羧酰胺的生物活性和晶体结构研究。由于这些酰胺在单一挥发性溶剂中的不溶性,晶体是在混合溶剂中生长的。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐